Market revenue in 2023 | USD 9,374.5 million |
Market revenue in 2030 | USD 13,323.6 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Basf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 71.53% in 2023. Horizon Databook has segmented the U.S. high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. accounted for the largest market share of North America high potency active pharmaceutical ingredient. High incidence of chronic diseases, rising awareness, and availability of advanced technology are among the factors propelling the market growth in the country.
According to the U.S. Department of Commerce’s Select USA, the U.S. is the largest market for biopharmaceuticals globally. The nation accounts for a third of the global market and is the global leader in biopharmaceutical R&D. Data from Pharmaceutical Research and Manufacturers of America indicates that the U.S. conducts approximately half the R&D for pharmaceuticals.
In addition, the country also holds majority of the intellectual rights on novel medicines and new chemical entity. Thus, the U.S. accounts for a substantial share of pharmaceutical and biopharmaceutical research.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. high potency active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into U.S. high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account